Evidence map›Paper›PMID 25633559›Full record

ArticleNeurogenetics2015

Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury.

John K Yue, Angela M Pronger, Adam R Ferguson, Nancy R Temkin, Sourabh Sharma, Jonathan Rosand, Marco D Sorani, Thomas W McAllister, Jason Barber, Ethan A Winkler and 10 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Neurogenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. DownstreamJournal of neurotrauma · 2019
    Article
  13. Review
  14. Article
  15. Regionally clusteredJournal of neurology, neurosurgery, and psychiatry · 2018
    Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

John K YueBrain and Spinal Injury Center, San Francisco General Hospital, San Francisco, CA, USA.
Angela M Pronger
Adam R Ferguson
Nancy R Temkin
Sourabh Sharma
Jonathan Rosand
Marco D Sorani
Thomas W McAllister
Jason Barber
Ethan A Winkler
Esteban G Burchard
Donglei Hu
Hester F Lingsma
Shelly R Cooper
Ava M Puccio
David O Okonkwo
Ramon Diaz-Arrastia
Geoffrey T Manley
COBRIT Investigators
TRACK-TBI Investigators
San Francisco General Hospital · USUniformed Services University of the Health Sciences · USBroad Institute · USUniversity of California, San Francisco · USErasmus MC · NL

Funding

Transforming Research and Clinical Knowledge in Traumatic Brain InjuryU01NS086090 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIAZ-ARRASTIA, RAMON, GIACINO, JOSEPH THOMAS · 2013 to 2017
$19.1M
Transforming Traumatic Brain Injury Research and Clinical CareRC2NS069409 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MANLEY, GEOFFREY T · 2009 to 2011
$4.3M
Traumatic Brain Injury Clinical Trials NetworkU01HD042652 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI DIAZ-ARRASTIA, RAMON · 2003 to 2012
$2.8M
Genetic factors in outcome from traumatic brain injuryR01HD048179 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI DIAZ-ARRASTIA, RAMON · 2004 to 2008
$1.8M
NICHD NIH HHS R01 HD048179NICHD NIH HHS R01 HD48179NICHD NIH HHS U01 HD042652NICHD NIH HHS U01 HD42652NINDS NIH HHS RC2 NS069409NINDS NIH HHS RC2 NS0694909NINDS NIH HHS U01 NS086090
6 · The paper itself

Abstract

Genetic association analyses suggest that certain common single nucleotide polymorphisms (SNPs) may adversely impact recovery from traumatic brain injury (TBI). Delineating their causal relationship may aid in development of novel interventions and in identifying patients likely to respond to targeted therapies. We examined the influence of the (C/T) SNP rs1800497 of ANKK1 on post-TBI outcome using data from two prospective multicenter studies: the Citicoline Brain Injury Treatment (COBRIT) trial and Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot). We included patients with ANKK1 genotyping results and cognitive outcomes at six months post-TBI (n = 492: COBRIT n = 272, TRACK-TBI Pilot n = 220). Using the California Verbal Learning Test Second Edition (CVLT-II) Trial 1-5 Standard Score, we found a dose-dependent effect for the T allele, with T/T homozygotes scoring lowest on the CVLT-II Trial 1-5 Standard Score (T/T 45.1, C/T 51.1, C/C 52.1, ANOVA, p = 0.008). Post hoc testing with multiple comparison-correction indicated that T/T patients performed significantly worse than C/T and C/C patients. Similar effects were observed in a test of non-verbal processing (Wechsler Adult Intelligence Scale, Processing Speed Index). Our findings extend those of previous studies reporting a negative relationship of the ANKK1 T allele with cognitive performance after TBI. In this study, we demonstrate the value of pooling shared clinical, biomarker, and outcome variables from two large datasets applying the NIH TBI Common Data Elements. The results have implications for future multicenter investigations to further elucidate the role of ANKK1 in post-TBI outcome.

Indexed as

CognitionAdultBrain InjuriesFemaleGenotypeHumansLearningMaleMemoryNeuropsychological TestsPolymorphism, Single NucleotideProspective StudiesProtein Serine-Threonine KinasesANKK1 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID25633559
PMCPMC5588885
OpenAlexW2044600370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.